Fully Reporting Company: $CBDY (Target Group, Inc.) Positioned to Serve the New Legal Cannabis Marketplace with High Quality Supply Sources and its Own Established Growth Facility
CBDY (Target Group Inc.) is a Vertically Integrated company in the Cannabis Sector with a Production Facility in Late Stage Application Status for Approval to Cultivate Under the Canadian Cannabis Act
Target Group, Inc. (OTC: CBDY) based in Ontario, Canada is a progressive, diversified, and vertically integrated cannabis investment company. Target Group is strategically aligned with a key subsidiary and industry partners to deliver high quality cannabis supplies in substantial quantity to the evolving worldwide cannabis marketing industry. CBDY has completed an impressive growth facility and is expanding operations to build an international network of manufacturing, distribution, production, and sales operations. This company is creating an iconic brand portfolio, leveraging product diversification, innovation, and operational expertise to solidify long-term growth and stability.
With major legislative changes that have recently occurred in Canada, the US and beyond, legalizing multipronged cannabis related product sale and use applications, we have seen swarms of new businesses emerging to seize upon the high revenue potential just created for them. The prolific spread of new CBD infused product marketers is the most obvious example, in addition to traditional medical and recreational products. All of these business niches are now growing at a rapid rate.
Target Group, with the very appropriate trading symbol of CBDY, is positioned with the assets, professional management experience and specific industry expertise to address the needs of the new cannabis related businesses emerging today. In addition to its multiple partner company sources, Target Group is developing its own high capacity cannabis agricultural growth facility for the many new CBD and related product marketing companies with dramatically increasing supply demands.
In May of 2019 CBDY’s wholly owned subsidiary, Canary Rx Inc. completed the build-out of a new 44,000 sq. ft. cannabis production facility in Norfolk County, Ontario. The state-of-the-art facility was designed by cannabis growers, for cannabis growers and engineered to meet Health Canada's rigorous quality and security standards. The production area is equipped with sophisticated environmental control technology, custom-built to regulate eight 2,200 sq. ft. flower rooms as well as vegetative, breeding, testing, and curing spaces. Once fully operational, this facility expected to produce 3,600kg of premium, organic cannabis per year.
Shortly after the opening of this facility Canary Rx submitted a Site Evidence Package to Health Canada pursuant to its Cultivation, Processing and Sales License application under the Canadian Cannabis Act. Submission marks the final step in Canary's bid to obtain a license to cultivate cannabis at the company's production facility.
In June CBDY reported that Canary Rx had entered a strategic alliance with CANABC Services Ltd. to provide vital consulting and distribution services to Micro License applicants. CANABC is a medical and regulatory consulting firm that has assisted more than 8,000 patients to obtain medical cannabis documents. CANABC will now offer a comprehensive suite of consulting services to assist Micro Cultivation, Processing and Nursery applicants to obtain a license under the Cannabis Act.
Micro License applicants often referred to as 'craft' growers, face many obstacles as they attempt to prepare a compliant facility and processes, obtain a license from Health Canada, and meet the ongoing regulatory compliance requirements. In contrast to traditional consulting firms, CANABC will provide fully-customized Standard Operating Procedures (SOPs) and Good Production Practices (GPPs) prepared by a Quality Assurance Specialist, and assist Micro's with ongoing compliance once licensed. Additionally, Canary will offer distribution services to Micro Cultivators that are restricted to selling cannabis to Licensed Producers under the current regulations.
Target Group has other partners as well, including Serious Seeds which is the home of classic, proprietary, award-winning cannabis strains such as AK-47, Bubble Gum, Chronic, Kali Mist, White Russian, and Serious Kush. Serious Seeds has been producing world renowned, premium cannabis strains since 1994. As of November 2018, Serious strains have received more than 101 cannabis industry awards globally. Their philosophy is to develop easy to grow, stable and homogenous genetics for medicinal and recreational cannabis consumers.
Also in Target Group’s Portfolio is CannaKorp, Inc., a Massachusetts-based technology start-up that is simplifying and improving the experience for consumers interested in vaporizing natural herbs. CannaKorp has developed the world’s first single-use pod, herbal vaporizer system, delivering unprecedented quality, convenience and consistency. The complete system includes the ground breaking vaporizer device, WISP™, single-use, precisely measured pods containing pre-ground, lab-tested botanical herbs called WISP Pods™; and a proprietary pod-filling process. CannaKorp, Inc. was founded on care and commitment to patients and consumers, and is guided by a philosophy of social and environmental responsibility.
In summary, Target Group (CBDY) is at a pivotal moment where an entire industry is just coming into play and this company is ready to participate in a very significant role. Learn more via the company websites:
Target Group, Inc. www.targetgroupinc.ca
Canary Rx Inc. www.canaryrx.com
Cannakorp: www.wispvapor.com
CANABC Services www.canabc.com
CBDY (Target Group Inc.) is a Vertically Integrated company in the Cannabis Sector with a Production Facility in Late Stage Application Status for Approval to Cultivate Under the Canadian Cannabis Act
Target Group, Inc. (OTC: CBDY) based in Ontario, Canada is a progressive, diversified, and vertically integrated cannabis investment company. Target Group is strategically aligned with a key subsidiary and industry partners to deliver high quality cannabis supplies in substantial quantity to the evolving worldwide cannabis marketing industry. CBDY has completed an impressive growth facility and is expanding operations to build an international network of manufacturing, distribution, production, and sales operations. This company is creating an iconic brand portfolio, leveraging product diversification, innovation, and operational expertise to solidify long-term growth and stability.
With major legislative changes that have recently occurred in Canada, the US and beyond, legalizing multipronged cannabis related product sale and use applications, we have seen swarms of new businesses emerging to seize upon the high revenue potential just created for them. The prolific spread of new CBD infused product marketers is the most obvious example, in addition to traditional medical and recreational products. All of these business niches are now growing at a rapid rate.
Target Group, with the very appropriate trading symbol of CBDY, is positioned with the assets, professional management experience and specific industry expertise to address the needs of the new cannabis related businesses emerging today. In addition to its multiple partner company sources, Target Group is developing its own high capacity cannabis agricultural growth facility for the many new CBD and related product marketing companies with dramatically increasing supply demands.
In May of 2019 CBDY’s wholly owned subsidiary, Canary Rx Inc. completed the build-out of a new 44,000 sq. ft. cannabis production facility in Norfolk County, Ontario. The state-of-the-art facility was designed by cannabis growers, for cannabis growers and engineered to meet Health Canada's rigorous quality and security standards. The production area is equipped with sophisticated environmental control technology, custom-built to regulate eight 2,200 sq. ft. flower rooms as well as vegetative, breeding, testing, and curing spaces. Once fully operational, this facility expected to produce 3,600kg of premium, organic cannabis per year.
Shortly after the opening of this facility Canary Rx submitted a Site Evidence Package to Health Canada pursuant to its Cultivation, Processing and Sales License application under the Canadian Cannabis Act. Submission marks the final step in Canary's bid to obtain a license to cultivate cannabis at the company's production facility.
In June CBDY reported that Canary Rx had entered a strategic alliance with CANABC Services Ltd. to provide vital consulting and distribution services to Micro License applicants. CANABC is a medical and regulatory consulting firm that has assisted more than 8,000 patients to obtain medical cannabis documents. CANABC will now offer a comprehensive suite of consulting services to assist Micro Cultivation, Processing and Nursery applicants to obtain a license under the Cannabis Act.
Micro License applicants often referred to as 'craft' growers, face many obstacles as they attempt to prepare a compliant facility and processes, obtain a license from Health Canada, and meet the ongoing regulatory compliance requirements. In contrast to traditional consulting firms, CANABC will provide fully-customized Standard Operating Procedures (SOPs) and Good Production Practices (GPPs) prepared by a Quality Assurance Specialist, and assist Micro's with ongoing compliance once licensed. Additionally, Canary will offer distribution services to Micro Cultivators that are restricted to selling cannabis to Licensed Producers under the current regulations.
Target Group has other partners as well, including Serious Seeds which is the home of classic, proprietary, award-winning cannabis strains such as AK-47, Bubble Gum, Chronic, Kali Mist, White Russian, and Serious Kush. Serious Seeds has been producing world renowned, premium cannabis strains since 1994. As of November 2018, Serious strains have received more than 101 cannabis industry awards globally. Their philosophy is to develop easy to grow, stable and homogenous genetics for medicinal and recreational cannabis consumers.
Also in Target Group’s Portfolio is CannaKorp, Inc., a Massachusetts-based technology start-up that is simplifying and improving the experience for consumers interested in vaporizing natural herbs. CannaKorp has developed the world’s first single-use pod, herbal vaporizer system, delivering unprecedented quality, convenience and consistency. The complete system includes the ground breaking vaporizer device, WISP™, single-use, precisely measured pods containing pre-ground, lab-tested botanical herbs called WISP Pods™; and a proprietary pod-filling process. CannaKorp, Inc. was founded on care and commitment to patients and consumers, and is guided by a philosophy of social and environmental responsibility.
In summary, Target Group (CBDY) is at a pivotal moment where an entire industry is just coming into play and this company is ready to participate in a very significant role. Learn more via the company websites:
Target Group, Inc. www.targetgroupinc.ca
Canary Rx Inc. www.canaryrx.com
Cannakorp: www.wispvapor.com
CANABC Services www.canabc.com
1
